Skin Diseases and Antibiotic Use

Dear Colleagues,

Antibiotics continue to serve as a fundamental therapeutic approach for addressing numerous skin diseases. However, their application is accompanied by formidable challenges and potential consequences within dermatological practice. These encompass the emergence of antibiotic resistance, leading to diminished efficacy and the possible development of superinfections. Furthermore, there is a recognized impact on the delicate equilibrium of the skin microbiome, alongside concerns regarding adverse drug reactions and overall patient safety associated with antibiotic use.

In response to these challenges, considerable attention is directed towards the development of novel antibiotics as well as the exploration of alternative therapeutic modalities that minimize the use of antibiotics and combination treatments. Integral to this endeavor is the concept of antibiotic stewardship, which prioritizes the judicious and optimized use of antibiotics to mitigate resistance development and ensure the enduring effectiveness of these agents for future generations.

This Special Issue aims to encompass a comprehensive examination of the challenges and advancements in antibiotic therapy for skin diseases. This Special Issue seeks to explore the multifaceted aspects of antibiotic use in dermatology, including mechanisms of antibiotic resistance, the impact on the skin microbiome, and strategies for optimizing antibiotic stewardship. Furthermore, it aims to highlight emerging research on novel antibiotics, alternatives to antibiotics in comparison to standard antibiotic therapy, and combination treatments for various dermatological conditions. By providing a platform for interdisciplinary dialogue and dissemination of cutting-edge research, this Special Issue endeavors to advance our understanding of antibiotic therapy in dermatology and its implications for clinical practice and public health. In this Special Issue, original research articles and reviews are welcome.

We look forward to receiving your contributions.

Dr. Dario Leskur
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• antibiotics
• antimicrobial resistance
• antibiotic stewardship
• dermatology
• cutaneous infection
• skin diseases